miR-762 Promotes Malignant Development of Head and Neck Squamous Cell Carcinoma by Targeting PHLPP2 and FOXO4.
Shuai ChenJian-Yun ZhangLi-Sha SunXue-Fen LiJia-Ying BaiHe-Yu ZhangTie-Jun LiPublished in: OncoTargets and therapy (2019)
miR-762 promotes HNSCC progression by targeting PHLPP2 and FOXO4. Therefore, miR-762 might be a potential diagnostic or therapeutic target for HNSCC.